Lung cancer and lung tissue array with smoking history (2015 WHO classification), 2 cores per case. Pathology grade, TNM, and clinical stage(small cell carcinoma reference AJCC 8th edition) information available.
- 11 cases of adenocarcinoma
- 21 cases of squamous cell carcinoma
- 2 cases of small cell carcinoma
- 1 case of adenosquamous carcinoma
- 5 cases of normal lung tissue
Price
$225.00
Catalogue No | RLC-821 |
Description | Lung cancer and lung tissue array with smoking history (2015 WHO classification), 2 cores per case. Pathology grade, TNM, and clinical stage(small cell carcinoma reference AJCC 8th edition) information available. |
Species | Human |
Fixative | Formalin |
Total Cases | 40 |
Total Cores | 80 |
Core Diameter | 1.5 mm |
Section Thickness | 5 µm |
Storage | Short term RT; Long term 4ºC |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
B | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
C | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
D | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
E | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
F | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
G | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
H | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type | History of smoking (year) | Dosage/day (stick) |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | A1 | 72 | M | Lung | Acinar adenocarcinoma | 1 | T1N0M0 | I | Malignant | 30 | 20 |
2 | A2 | 72 | M | Lung | Acinar adenocarcinoma | 1 | T1N0M0 | I | Malignant | 30 | 20 |
3 | A3 | 71 | M | Lung | Acinar adenocarcinoma | 2 | T3N0M0 | IIB | Malignant | 30 | 30 |
4 | A4 | 71 | M | Lung | Acinar adenocarcinoma | 2 | T3N0M0 | IIB | Malignant | 30 | 30 |
5 | A5 | 64 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant | 40 | 25 |
6 | A6 | 64 | M | Lung | Acinar adenocarcinoma (sparse) | * | T2aN0M0 | IB | Malignant | 40 | 25 |
7 | A7 | 70 | M | Lung | Acinar adenocarcinoma | 2 | T1bN0M0 | IA | Malignant | 45 | 20 |
8 | A8 | 70 | M | Lung | Acinar adenocarcinoma | 2 | T1bN0M0 | IA | Malignant | 45 | 20 |
9 | A9 | 57 | M | Lung | Acinar adenocarcinoma | 2--3 | T2aN0M0 | IB | Malignant | 30 | 15~20 |
10 | A10 | 57 | M | Lung | Acinar adenocarcinoma | 2--3 | T2aN0M0 | IB | Malignant | 30 | 15~20 |
11 | B1 | 48 | F | Lung | Acinar adenocarcinoma | 2--3 | T2N0M0 | IB | Malignant | 20 | 20 |
12 | B2 | 48 | F | Lung | Acinar adenocarcinoma | 2--3 | T2N0M0 | IB | Malignant | 20 | 20 |
13 | B3 | 75 | M | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | 55 | 30 |
14 | B4 | 75 | M | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | 55 | 30 |
15 | B5 | 67 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | 20 | 10 |
16 | B6 | 67 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | 20 | 10 |
17 | B7 | 65 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | 50 | 25 |
18 | B8 | 65 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant | 50 | 25 |
19 | B9 | 42 | M | Lung | Mucinous papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant | 20 | 20 |
20 | B10 | 42 | M | Lung | Mucinous papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant | 20 | 20 |
21 | C1 | 62 | M | Lung | Mixed mucinous and non-mucinous adenocarcinoma | 2 | T1N0M0 | I | Malignant | 40 | 15 |
22 | C2 | 62 | M | Lung | Mixed mucinous and non-mucinous adenocarcinoma | 2 | T1N0M0 | I | Malignant | 40 | 15 |
23 | C3 | 59 | F | Lung | Adenosquamous carcinoma | - | T3N0M0 | IIB | Malignant | 20 | 10 |
24 | C4 | 59 | F | Lung | Adenosquamous carcinoma | - | T3N0M0 | IIB | Malignant | 20 | 10 |
25 | C5 | 74 | M | Lung | Keratinized squamous cell carcinoma | 1--2 | T3N0M0 | IIB | Malignant | 40 | 20 |
26 | C6 | 74 | M | Lung | Keratinized squamous cell carcinoma | 1--2 | T3N0M0 | IIB | Malignant | 40 | 20 |
27 | C7 | 66 | M | Lung | Keratinized squamous cell carcinoma | 1--2 | T2aN0M0 | IB | Malignant | 45 | 25 |
28 | C8 | 66 | M | Lung | Keratinized squamous cell carcinoma | 1--2 | T2aN0M0 | IB | Malignant | 45 | 25 |
29 | C9 | 65 | M | Lung | Keratinized squamous cell carcinoma | 1--2 | T2bN0M0 | IIB | Malignant | 40 | 20 |
30 | C10 | 65 | M | Lung | Keratinized squamous cell carcinoma | 1--2 | T2bN0M0 | IIB | Malignant | 40 | 20 |
31 | D1 | 57 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant | 20 | 15 |
32 | D2 | 57 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant | 20 | 15 |
33 | D3 | 56 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2N1M0 | IIA | Malignant | 30 | 20~40 |
34 | D4 | 56 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2N1M0 | IIA | Malignant | 30 | 20~40 |
35 | D5 | 73 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2aN1M0 | IIA | Malignant | 57 | 20 |
36 | D6 | 73 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2aN1M0 | IIA | Malignant | 57 | 20 |
37 | D7 | 49 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2bN1M0 | IIB | Malignant | 29 | 20 |
38 | D8 | 49 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2bN1M0 | IIB | Malignant | 29 | 20 |
39 | D9 | 65 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2bN1M0 | IIB | Malignant | 40 | 30 |
40 | D10 | 65 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2bN1M0 | IIB | Malignant | 40 | 30 |
41 | E1 | 68 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant | 40 | 25 |
42 | E2 | 68 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant | 40 | 25 |
43 | E3 | 72 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2bN1M0 | IIB | Malignant | 57 | 20-40 |
44 | E4 | 72 | M | Lung | Non-keratinized squamous cell carcinoma | 2 | T2bN1M0 | IIB | Malignant | 57 | 20-40 |
45 | E5 | 73 | M | Lung | Non-keratinized squamous cell carcinoma | 2--3 | T2aN0M0 | IB | Malignant | 50 | 20 |
46 | E6 | 73 | M | Lung | Non-keratinized squamous cell carcinoma | 2--3 | T2aN0M0 | IB | Malignant | 50 | 20 |
47 | E7 | 70 | M | Lung | Non-keratinized squamous cell carcinoma | 2--3 | T2aN0M0 | IB | Malignant | 50 | 20 |
48 | E8 | 70 | M | Lung | Non-keratinized squamous cell carcinoma | 2--3 | T2aN0M0 | IB | Malignant | 50 | 20 |
49 | E9 | 67 | M | Lung | Non-keratinized squamous cell carcinoma | 2--3 | T2aN0M0 | IB | Malignant | 30 | 30 |
50 | E10 | 67 | M | Lung | Non-keratinized squamous cell carcinoma | 2--3 | T2aN0M0 | IB | Malignant | 30 | 30 |
51 | F1 | 66 | M | Lung | Non-keratinized squamous cell carcinoma | 2--3 | T2aN0M0 | IB | Malignant | 40 | 20 |
52 | F2 | 66 | M | Lung | Non-keratinized squamous cell carcinoma | 2--3 | T2aN0M0 | IB | Malignant | 40 | 20 |
53 | F3 | 58 | M | Lung | Non-keratinized squamous cell carcinoma | 2--3 | T3N1M0 | IIIA | Malignant | 25 | 15 |
54 | F4 | 58 | M | Lung | Non-keratinized squamous cell carcinoma | 2--3 | T3N1M0 | IIIA | Malignant | 25 | 15 |
55 | F5 | 45 | M | Lung | Non-keratinized squamous cell carcinoma | 2--3 | T4N1M0 | IIIA | Malignant | 25 | 20 |
56 | F6 | 45 | M | Lung | Non-keratinized squamous cell carcinoma | 2--3 | T4N1M0 | IIIA | Malignant | 25 | 20 |
57 | F7 | 62 | M | Lung | Non-keratinized squamous cell carcinoma | 3 | T2aN1M0 | IIA | Malignant | 40 | 25 |
58 | F8 | 62 | M | Lung | Non-keratinized squamous cell carcinoma | 3 | T2aN1M0 | IIA | Malignant | 40 | 25 |
59 | F9 | 74 | M | Lung | Non-keratinized squamous cell carcinoma | 3 | T2aN1M0 | IIA | Malignant | 50 | 20 |
60 | F10 | 74 | M | Lung | Non-keratinized squamous cell carcinoma | 3 | T2aN1M0 | IIA | Malignant | 50 | 20 |
61 | G1 | 55 | M | Lung | Non-keratinized squamous cell carcinoma | 3 | T2aN1M0 | IIA | Malignant | 25 | 25 |
62 | G2 | 55 | M | Lung | Non-keratinized squamous cell carcinoma | 3 | T2aN1M0 | IIA | Malignant | 25 | 25 |
63 | G3 | 55 | M | Lung | Non-keratinized squamous cell carcinoma | 3 | T2bN0M0 | IIB | Malignant | 25 | 10 |
64 | G4 | 55 | M | Lung | Non-keratinized squamous cell carcinoma | 3 | T2bN0M0 | IIB | Malignant | 25 | 10 |
65 | G5 | 55 | M | Lung | Non-keratinized squamous cell carcinoma | 3 | T3N1M0 | IIIA | Malignant | 30 | 10 |
66 | G6 | 55 | M | Lung | Non-keratinized squamous cell carcinoma | 3 | T3N1M0 | IIIA | Malignant | 30 | 10 |
67 | G7 | 62 | M | Lung | Combined small cell carcinoma | - | T2aN1M0 | IIA | Malignant | 40 | 25 |
68 | G8 | 62 | M | Lung | Combined small cell carcinoma | - | T2aN1M0 | IIA | Malignant | 40 | 25 |
69 | G9 | 33 | M | Lung | Small cell carcinoma | - | T2aN2M0 | IIIA | Malignant | 18 | 25 |
70 | G10 | 33 | M | Lung | Small cell carcinoma | - | T2aN2M0 | IIIA | Malignant | 18 | 25 |
71 | H1 | 24 | M | Lung | Normal Lung Tissue | - | - | - | Normal | No info. | No info. |
72 | H2 | 24 | M | Lung | Normal Lung Tissue | - | - | - | Normal | No info. | No info. |
73 | H3 | 48 | M | Lung | Normal Lung Tissue | - | - | - | Normal | No info. | No info. |
74 | H4 | 48 | M | Lung | Normal Lung Tissue | - | - | - | Normal | No info. | No info. |
75 | H5 | 47 | M | Lung | Normal Lung Tissue | - | - | - | Normal | No info. | No info. |
76 | H6 | 47 | M | Lung | Normal Lung Tissue | - | - | - | Normal | No info. | No info. |
77 | H7 | 47 | M | Lung | Normal Lung Tissue | - | - | - | Normal | No info. | No info. |
78 | H8 | 47 | M | Lung | Normal Lung Tissue | - | - | - | Normal | No info. | No info. |
79 | H9 | 21 | F | Lung | Normal Lung Tissue | - | - | - | Normal | No info. | No info. |
80 | H10 | 21 | F | Lung | Normal Lung Tissue | - | - | - | Normal | No info. | No info. |